FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 196 filers reported holding FIBROGEN INC in Q2 2018. The put-call ratio across all filers is 3.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $28,553,000 | +16.1% | 525,355 | -1.2% | 0.03% | 0.0% |
| Q4 2018 | $24,601,000 | -23.4% | 531,578 | +0.6% | 0.03% | -6.7% |
| Q3 2018 | $32,111,000 | -2.5% | 528,568 | +0.4% | 0.03% | -6.2% |
| Q2 2018 | $32,949,000 | +119.4% | 526,343 | +61.9% | 0.03% | +113.3% |
| Q1 2018 | $15,017,000 | +14.4% | 325,054 | +17.4% | 0.02% | +15.4% |
| Q4 2017 | $13,126,000 | +8.4% | 276,914 | +23.1% | 0.01% | +8.3% |
| Q3 2017 | $12,105,000 | – | 225,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $7,880,000 | 4.60% |
| ARMISTICE CAPITAL, LLC | 4,456,000 | $57,973,000 | 1.01% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $2,489,000 | 0.78% |
| BHK Investment Advisors, LLC | 87,450 | $1,138,000 | 0.57% |
| Soleus Capital Management, L.P. | 234,026 | $3,045,000 | 0.41% |
| Tri Locum Partners LP | 74,348 | $967,000 | 0.26% |
| Point72 Asset Management, L.P. | 4,777,700 | $62,158,000 | 0.25% |
| PRIMECAP MANAGEMENT CO/CA/ | 13,179,897 | $171,470,000 | 0.17% |
| Newbridge Financial Services Group, Inc. | 20,285 | $264,000 | 0.16% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,430,526 | $18,611,000 | 0.15% |